{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:17Z","timestamp":1791312797549,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.arth.2020.06.040","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T03:35:47Z","timestamp":1593228947000},"page":"3099-3107.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk Factors for Chronic Opioid Use Following Hip and Knee Arthroplasty: Evidence from New Zealand Population Data"],"prefix":"10.1016","volume":"35","author":[{"given":"Yana","family":"Pryymachenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-8081","authenticated-orcid":false,"given":"Ross A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Haxby","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Dowsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.M.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2020.06.040_bib1","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1186\/ar1782","article-title":"Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arth.2020.06.040_bib2","article-title":"A\u00a0review of potential adverse effects of long-term opioid therapy: a practitioner\u2019s guide","volume":"14","author":"Baldini","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.arth.2020.06.040_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v27n01_01","article-title":"The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits","volume":"27","author":"Wisniewski","year":"2008","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.arth.2020.06.040_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","article-title":"Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005\u20132011","volume":"33","author":"Fischer","year":"2014","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.arth.2020.06.040_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.puhe.2012.04.010","article-title":"Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001","volume":"126","author":"Fischer","year":"2012","journal-title":"Public Health"},{"key":"10.1016\/j.arth.2020.06.040_bib7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2106\/JBJS.17.01617","article-title":"Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030","volume":"100","author":"Sloan","year":"2018","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2020.06.040_bib8","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.arth.2017.03.014","article-title":"Opioid use after total knee arthroplasty: trends and risk factors for prolonged use","volume":"32","author":"Bedard","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib9","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.arth.2017.08.010","article-title":"Opioid use following total hip arthroplasty: trends and risk factors for prolonged use","volume":"32","author":"Bedard","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib10","first-page":"33","article-title":"Long-term opioid medication use before and after joint replacement surgery in New Zealand","volume":"132","author":"Wilson","year":"2019","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.arth.2020.06.040_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.arth.2018.12.023","article-title":"Benchmarks of duration and magnitude of opioid consumption after total hip and knee arthroplasty: a database analysis of 69,368 patients","volume":"34","author":"Cook","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/0310057X1704500609","article-title":"Prevalence and predictors of persistent post-surgical opioid use: a prospective observational study","volume":"45","author":"Stark","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.arth.2020.06.040_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/bja\/87.1.88","article-title":"Chronic pain after surgery","volume":"87","author":"Macrae","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.arth.2020.06.040_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/BRS.0000000000002133","article-title":"Predictors of long-term opioid use following lumbar fusion surgery","volume":"42","author":"Connolly","year":"2017","journal-title":"Spine"},{"key":"10.1016\/j.arth.2020.06.040_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.arth.2020.06.040_bib16","series-title":"New Zealand Joint Registry nineteen year report (January 1999 - December 2017)","year":"2018"},{"key":"10.1016\/j.arth.2020.06.040_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ije\/dyz014","article-title":"Data resource profile: the New Zealand integrated Data infrastructure (IDI)","volume":"48","author":"Milne","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.arth.2020.06.040_bib18","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.arth.2019.05.050","article-title":"Chronic prescription opioid use before and after total hip and knee arthroplasty in patients younger than 65 years","volume":"34","author":"Chen","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib19","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2020.06.040_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamainternmed.2016.3298","article-title":"Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period","volume":"176","author":"Sun","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arth.2020.06.040_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jhsa.2016.07.113","article-title":"Risk of prolonged opioid use among opioid-na\u00efve patients following common hand surgery procedures","volume":"41","author":"Johnson","year":"2016","journal-title":"J\u00a0Hand Surg Am"},{"key":"10.1016\/j.arth.2020.06.040_bib22","series-title":"NZDep2013 index of deprivation","author":"Atkinson","year":"2014"},{"key":"10.1016\/j.arth.2020.06.040_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2020.06.040_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.MLR.0000064641.84967.B7","article-title":"Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument","volume":"41","author":"Sloan","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2020.06.040_bib25","series-title":"R: a language and environment for statistical computing","year":"2017"},{"key":"10.1016\/j.arth.2020.06.040_bib26","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.5435\/JAAOS-D-19-00156","article-title":"Spinal anesthesia is associated with decreased complications after total knee and hip arthroplasty","volume":"28","author":"Warren","year":"2020","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"6 Suppl B","key":"10.1016\/j.arth.2020.06.040_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1427.R1","article-title":"Not all hip arthroplasties are created equal: increased complications and re-admissions after total hip arthroplasty for femoral neck fractures compared with osteoarthritis","volume":"101-B","author":"Charette","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2020.06.040_bib28","first-page":"69","article-title":"Differences between prescribed and dispensed medications","volume":"109","author":"Gardner","year":"1996","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.arth.2020.06.040_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2013.02.016","article-title":"Agreement between patient interview data on prescription medication use and pharmacy records in those aged older than 50 years varied by therapeutic group and reporting of indicated health conditions","volume":"66","author":"Richardson","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.arth.2020.06.040_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.arth.2015.11.022","article-title":"Rationing for total hip and knee arthroplasty using the New Zealand Orthopaedic Association score: effectiveness and comparison with patient-reported scores","volume":"31","author":"Gwynne-Jones","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib31","doi-asserted-by":"crossref","first-page":"e010664","DOI":"10.1136\/bmjopen-2015-010664","article-title":"Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study","volume":"6","author":"Inacio","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.arth.2020.06.040_bib32","doi-asserted-by":"crossref","first-page":"R248","DOI":"10.1186\/ar4091","article-title":"Predictors of use of pain medications for persistent knee pain after primary total knee arthroplasty: a cohort study using an institutional joint registry","volume":"14","author":"Singh","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arth.2020.06.040_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2474-11-90","article-title":"Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years","volume":"11","author":"Singh","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2020.06.040_bib34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.arth.2018.03.068","article-title":"Patient factors associated with prolonged postoperative opioid use after total knee arthroplasty","volume":"33","author":"Namba","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib35","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.joca.2017.04.002","article-title":"Patterns and predictors of persistent opioid use following hip or knee arthroplasty","volume":"25","author":"Kim","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.arth.2020.06.040_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.arth.2019.01.054","article-title":"Freedom from opioids after total knee arthroplasty","volume":"34","author":"Kuo","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2106\/JBJS.18.01005","article-title":"Preoperative risk factors for opioid utilization after total hip arthroplasty","volume":"101","author":"Prentice","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2020.06.040_bib38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.arth.2020.04.012","article-title":"Increased use of intra-articular steroid injection to treat osteoarthritis is associated with chronic opioid dependence after later total knee arthroplasty but not total hip arthroplasty","volume":"35","author":"Wilson","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamasurg.2019.2875","article-title":"Association of decreased postsurgical opioid prescribing with patients\u2019 satisfaction with surgeons","volume":"154","author":"Louie","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.arth.2020.06.040_bib40","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.arth.2019.02.022","article-title":"Restrictive opioid prescribing protocols following total hip arthroplasty and total knee arthroplasty are safe and effective","volume":"34","author":"Holte","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2020.06.040_bib41","first-page":"CD003115","article-title":"Oral or transdermal opioids for osteoarthritis of the knee or hip","author":"da Costa","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arth.2020.06.040_bib42","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular arthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.arth.2020.06.040_bib43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs non- opioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540320306847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540320306847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:31:46Z","timestamp":1760121106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540320306847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0883540320306847"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2020.06.040","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Chronic Opioid Use Following Hip and Knee Arthroplasty: Evidence from New Zealand Population Data","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2020.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}